Kadcyla 160 MG vials
Ended Awarded
- Contract number
- SPE2DB25FKEGF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,971
Award facts
- Contract value 100% obligated
- $16,971.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,971.28 to DMS Pharmaceutical Group Inc. for 160 mg vials of Kadcyla, an oncology medication, with a completion deadline of June 13, 2025. This firm fixed-price delivery order, issued on May 22, 2025, does not carry a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The company is registered in SAM.gov and holds extensive federal contracting experience, particularly with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. Through this contract vehicle, the company supplies a comprehensive range of pharmaceutical products to support military healthcare facility needs nationwide, including branded and generic prescription drugs, biologics, over-the-counter medications, and specialty treatments. The IDC framework allows DLA to issue firm fixed-price delivery orders for specific pharmaceutical items as needed to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKEGF?
SPE2DB25FKEGF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 22, 2025.
How much is contract SPE2DB25FKEGF worth?
The government has obligated $16,971 on SPE2DB25FKEGF.
Is contract SPE2DB25FKEGF an order under another contract?
Yes. SPE2DB25FKEGF is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEGF competed?
The extent of competition for SPE2DB25FKEGF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award